Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
about
Loss of SLCO1B3 drives taxane resistance in prostate cancerCabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations.Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model.
P2860
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
@en
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
@nl
type
label
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
@en
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
@nl
prefLabel
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
@en
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
@nl
P2093
P2860
P356
P1433
P1476
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation
@en
P2093
Ashraf Aghai
Corrina de Ridder
Ellen de Morrée
Herman Burger
Inge Ghobadi Moghaddam-Helmantel
Peter de Bruijn
Ron Mathijssen
Ronald de Wit
Wytske van Weerden
P2860
P304
P356
10.1002/PROS.23182
P577
2016-03-21T00:00:00Z